Cargando…

Fahr’s syndrome: literature review of current evidence

Fahr’s disease or Fahr’s syndrome is a rare, neurological disorder characterized by abnormal calcified deposits in basal ganglia and cerebral cortex. Calcified deposits are made up of calcium carbonate and calcium phosphate, and are commonly located in the Basal Ganglia, Thalamus, Hippocampus, Cereb...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleem, Shafaq, Aslam, Hafiz Muhammad, Anwar, Maheen, Anwar, Shahzad, Saleem, Maria, Saleem, Anum, Rehmani, Muhammad Asim Khan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853434/
https://www.ncbi.nlm.nih.gov/pubmed/24098952
http://dx.doi.org/10.1186/1750-1172-8-156
_version_ 1782294632268300288
author Saleem, Shafaq
Aslam, Hafiz Muhammad
Anwar, Maheen
Anwar, Shahzad
Saleem, Maria
Saleem, Anum
Rehmani, Muhammad Asim Khan
author_facet Saleem, Shafaq
Aslam, Hafiz Muhammad
Anwar, Maheen
Anwar, Shahzad
Saleem, Maria
Saleem, Anum
Rehmani, Muhammad Asim Khan
author_sort Saleem, Shafaq
collection PubMed
description Fahr’s disease or Fahr’s syndrome is a rare, neurological disorder characterized by abnormal calcified deposits in basal ganglia and cerebral cortex. Calcified deposits are made up of calcium carbonate and calcium phosphate, and are commonly located in the Basal Ganglia, Thalamus, Hippocampus, Cerebral cortex, Cerebellar Subcortical white matter and Dentate Nucleus. Molecular genetics of this disease haven’t been studied extensively; hence evidence at the molecular and genetic level is limited. Fahr’s disease commonly affects young to middle aged adults. Etiology of this syndrome does not identify a specific agent but associations with a number of conditions have been noted; most common of which are endocrine disorders, mitochondrial myopathies, dermatological abnormalities and infectious diseases. Clinical manifestations of this disease incorporate a wide variety of symptoms, ranging from neurological symptoms of extrapyramidal system to neuropsychiatric abnormalities of memory and concentration to movement disorders including Parkinsonism, chorea and tremors amongst others. Diagnostic criteria for this disease has been formulated after modifications from previous evidence and can be stated briefly, it consist of bilateral calcification of basal ganglia, progressive neurologic dysfunction, absence of biochemical abnormalities, absence of an infectious, traumatic or toxic cause and a significant family history. Imaging modalities for the diagnosis include CT, MRI, and plain radiography of skull. Other investigations include blood and urine testing for hematologic and biochemical indices. Disease is as yet incurable but management and treatment strategies mainly focus on symptomatic relief and eradication of causative factors; however certain evidence is present to suggest that early diagnosis and treatment can reverse the calcification process leading to complete recovery of mental functions. Families with a known history of Fahr’s disease should be counseled prior to conception so that the birth of affected babies can be prevented. This review was written with the aim to remark on the current substantial evidence surrounding this disease.
format Online
Article
Text
id pubmed-3853434
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38534342013-12-07 Fahr’s syndrome: literature review of current evidence Saleem, Shafaq Aslam, Hafiz Muhammad Anwar, Maheen Anwar, Shahzad Saleem, Maria Saleem, Anum Rehmani, Muhammad Asim Khan Orphanet J Rare Dis Review Fahr’s disease or Fahr’s syndrome is a rare, neurological disorder characterized by abnormal calcified deposits in basal ganglia and cerebral cortex. Calcified deposits are made up of calcium carbonate and calcium phosphate, and are commonly located in the Basal Ganglia, Thalamus, Hippocampus, Cerebral cortex, Cerebellar Subcortical white matter and Dentate Nucleus. Molecular genetics of this disease haven’t been studied extensively; hence evidence at the molecular and genetic level is limited. Fahr’s disease commonly affects young to middle aged adults. Etiology of this syndrome does not identify a specific agent but associations with a number of conditions have been noted; most common of which are endocrine disorders, mitochondrial myopathies, dermatological abnormalities and infectious diseases. Clinical manifestations of this disease incorporate a wide variety of symptoms, ranging from neurological symptoms of extrapyramidal system to neuropsychiatric abnormalities of memory and concentration to movement disorders including Parkinsonism, chorea and tremors amongst others. Diagnostic criteria for this disease has been formulated after modifications from previous evidence and can be stated briefly, it consist of bilateral calcification of basal ganglia, progressive neurologic dysfunction, absence of biochemical abnormalities, absence of an infectious, traumatic or toxic cause and a significant family history. Imaging modalities for the diagnosis include CT, MRI, and plain radiography of skull. Other investigations include blood and urine testing for hematologic and biochemical indices. Disease is as yet incurable but management and treatment strategies mainly focus on symptomatic relief and eradication of causative factors; however certain evidence is present to suggest that early diagnosis and treatment can reverse the calcification process leading to complete recovery of mental functions. Families with a known history of Fahr’s disease should be counseled prior to conception so that the birth of affected babies can be prevented. This review was written with the aim to remark on the current substantial evidence surrounding this disease. BioMed Central 2013-10-08 /pmc/articles/PMC3853434/ /pubmed/24098952 http://dx.doi.org/10.1186/1750-1172-8-156 Text en Copyright © 2013 saleem et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Saleem, Shafaq
Aslam, Hafiz Muhammad
Anwar, Maheen
Anwar, Shahzad
Saleem, Maria
Saleem, Anum
Rehmani, Muhammad Asim Khan
Fahr’s syndrome: literature review of current evidence
title Fahr’s syndrome: literature review of current evidence
title_full Fahr’s syndrome: literature review of current evidence
title_fullStr Fahr’s syndrome: literature review of current evidence
title_full_unstemmed Fahr’s syndrome: literature review of current evidence
title_short Fahr’s syndrome: literature review of current evidence
title_sort fahr’s syndrome: literature review of current evidence
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853434/
https://www.ncbi.nlm.nih.gov/pubmed/24098952
http://dx.doi.org/10.1186/1750-1172-8-156
work_keys_str_mv AT saleemshafaq fahrssyndromeliteraturereviewofcurrentevidence
AT aslamhafizmuhammad fahrssyndromeliteraturereviewofcurrentevidence
AT anwarmaheen fahrssyndromeliteraturereviewofcurrentevidence
AT anwarshahzad fahrssyndromeliteraturereviewofcurrentevidence
AT saleemmaria fahrssyndromeliteraturereviewofcurrentevidence
AT saleemanum fahrssyndromeliteraturereviewofcurrentevidence
AT rehmanimuhammadasimkhan fahrssyndromeliteraturereviewofcurrentevidence